Molecular pathways: connecting fibrosis and solid tumor metastasis

Thomas R Cox; Janine Terra Erler

doi:10.1158/1078-0432.ccr-13-1059

Molecular pathways: connecting fibrosis and solid tumor metastasis

74 Citationer (Scopus)

Abstract

Pathologic organ fibrosis is a condition that can affect all major tissues and is typically ascribed to the excessive accumulation of extracellular matrix components, predominantly collagens. It typically leads to compromise of organ function and subsequent organ failure, and it is estimated that 45% of deaths in the developed world are linked to fibrotic disease. Fibrosis and cancer are known to be inextricably linked; however, we are only just beginning to understand the common and overlapping molecular pathways between the two. Here, we discuss what is known about the intersection of fibrosis and cancer, with a focus on cancer metastasis, and highlight some of the exciting new potential clinical targets that are emerging from analysis of the molecular pathways associated with these two devastating diseases.

Originalsprog	Engelsk
Tidsskrift	Clinical Cancer Research
Vol/bind	20
Udgave nummer	14
Sider (fra-til)	3637-43
Antal sider	7
ISSN	1078-0432
DOI	https://doi.org/10.1158/1078-0432.ccr-13-1059
Status	Udgivet - 15 jul. 2014

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1158/1078-0432.ccr-13-1059

https://clincancerres.aacrjournals.org/content/clincanres/20/14/3637.full.pdf

Citationsformater

@article{c431a9e259714fc3a48c923fe56ba4cf,

title = "Molecular pathways: connecting fibrosis and solid tumor metastasis",

abstract = "Pathologic organ fibrosis is a condition that can affect all major tissues and is typically ascribed to the excessive accumulation of extracellular matrix components, predominantly collagens. It typically leads to compromise of organ function and subsequent organ failure, and it is estimated that 45% of deaths in the developed world are linked to fibrotic disease. Fibrosis and cancer are known to be inextricably linked; however, we are only just beginning to understand the common and overlapping molecular pathways between the two. Here, we discuss what is known about the intersection of fibrosis and cancer, with a focus on cancer metastasis, and highlight some of the exciting new potential clinical targets that are emerging from analysis of the molecular pathways associated with these two devastating diseases.",

author = "Cox, {Thomas R} and Erler, {Janine Terra}",

note = "{\textcopyright}2014 American Association for Cancer Research.",

year = "2014",

month = jul,

day = "15",

doi = "10.1158/1078-0432.ccr-13-1059",

language = "English",

volume = "20",

pages = "3637--43",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research (A A C R)",

number = "14",

}

TY - JOUR

T1 - Molecular pathways

T2 - connecting fibrosis and solid tumor metastasis

AU - Cox, Thomas R

AU - Erler, Janine Terra

PY - 2014/7/15

Y1 - 2014/7/15

N2 - Pathologic organ fibrosis is a condition that can affect all major tissues and is typically ascribed to the excessive accumulation of extracellular matrix components, predominantly collagens. It typically leads to compromise of organ function and subsequent organ failure, and it is estimated that 45% of deaths in the developed world are linked to fibrotic disease. Fibrosis and cancer are known to be inextricably linked; however, we are only just beginning to understand the common and overlapping molecular pathways between the two. Here, we discuss what is known about the intersection of fibrosis and cancer, with a focus on cancer metastasis, and highlight some of the exciting new potential clinical targets that are emerging from analysis of the molecular pathways associated with these two devastating diseases.

AB - Pathologic organ fibrosis is a condition that can affect all major tissues and is typically ascribed to the excessive accumulation of extracellular matrix components, predominantly collagens. It typically leads to compromise of organ function and subsequent organ failure, and it is estimated that 45% of deaths in the developed world are linked to fibrotic disease. Fibrosis and cancer are known to be inextricably linked; however, we are only just beginning to understand the common and overlapping molecular pathways between the two. Here, we discuss what is known about the intersection of fibrosis and cancer, with a focus on cancer metastasis, and highlight some of the exciting new potential clinical targets that are emerging from analysis of the molecular pathways associated with these two devastating diseases.

U2 - 10.1158/1078-0432.ccr-13-1059

DO - 10.1158/1078-0432.ccr-13-1059

M3 - Review

C2 - 25028505

SN - 1078-0432

VL - 20

SP - 3637

EP - 3643

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 14

ER -

Molecular pathways: connecting fibrosis and solid tumor metastasis

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater